Skip to content

The impact of sarcopenia on the clinical outcomes following minimally invasive transforaminal lumbar interbody fusion

The impact of sarcopenia on the clinical outcomes following minimally invasive transforaminal lumbar interbody fusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031308
Enrollment
Unknown
Registered
2020-03-27
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar degenerative diseases

Interventions

Sarcopenia :None
Control group:None

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 65 years; 2. Patients with intermittent claudication or lumbago accompanied by lower extremity pain and numbness; 3. The type of imaging manifestation is round and oval spinal stenosis, which can be achieved by bilateral decompression through unilateral approach; 4. Patients with single segment lumbar spinal stenosis and lumbar instability (lumbar instability refers to the lateral slide of lumbar dynamic film more than 3 mm or the angle of upper and lower vertebral endplate greater than 11 degree); 5. Patients with lumbar degenerative or isthmic spondylolisthesis (within meyerding index I) who need surgical treatment; 6. Patients whose symptoms last for 6 months, and whose normal conservative treatment is ineffective, seriously affect their lives.

Exclusion criteria

Exclusion criteria: 1. Patients with severe bilateral spinal stenosis (also known as trilobal stenosis) accompanied by symptoms of both lower limbs and patients whose preoperative evaluation indicated that unilateral approach was difficult to achieve decompression of contralateral recess or intervertebral foramen; 2. Patients with spinal surgery, lumbar fracture, active infection and spinal tumor; 3. Patients with coronal or sagittal malformations requiring surgical treatment; 4. Meyerding grade II or above slip; 5. Patients who are not suitable for surgery due to any internal medicine, mental and psychological diseases.

Design outcomes

Primary

MeasureTime frame
Operation time;Intraoperative blood loss;Radiation exposure;Length of hospital stay;Complications;VAS score for back pain and leg pain (preoperatively, and postoperatively at 3, 6, 12 months and last follow up);JOA score (preoperatively, and postoperatively at 12 months and last follow up);ODI score (preoperatively, and postoperatively at 12 months and last follow up);Fusion rate (at last follow up).;Skeletal muscle mass;Handgrip strength;

Secondary

MeasureTime frame
Gender;Age;Body mass index;Bone mineral density;Disease course;Distribution of treated segment;Psoas muscle index;

Countries

China

Contacts

Public ContactGuangfei Gu

Spine Surgery, Shanghai Tenth People's Hospital

guguangfei01@163.com+86 21 66307270

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026